AI Health Technology Limited (HKG:1715)
Hong Kong
· Delayed Price · Currency is HKD 0.520
-0.010 (-1.89%)
At close: Apr 29, 2026
AI Health Technology Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 47.4 | 91.89 | 84.37 | 88.19 | 143.87 | Upgrade
|
| Revenue Growth (YoY) | -48.41% | 8.91% | -4.33% | -38.71% | -24.03% | Upgrade
|
| Cost of Revenue | 43.14 | 85.4 | 63.15 | 49.7 | 78.6 | Upgrade
|
| Gross Profit | 4.26 | 6.49 | 21.22 | 38.49 | 65.27 | Upgrade
|
| Selling, General & Admin | 34.35 | 31.87 | 53.11 | 70.92 | 100.19 | Upgrade
|
| Research & Development | 5.76 | 5.87 | 6.94 | 7.99 | 10.54 | Upgrade
|
| Other Operating Expenses | -3.62 | -3.83 | -3.18 | -2.79 | -4.84 | Upgrade
|
| Operating Expenses | 36.49 | 37.93 | 62.58 | 78.19 | 105.88 | Upgrade
|
| Operating Income | -32.22 | -31.45 | -41.37 | -39.7 | -40.61 | Upgrade
|
| Interest Expense | -3.14 | -4.16 | -7.72 | -5.06 | -1.51 | Upgrade
|
| Interest & Investment Income | 0.42 | 0.01 | 0.01 | 0.06 | 0.09 | Upgrade
|
| Earnings From Equity Investments | -1.03 | -0.34 | -0.57 | -0.39 | -0.74 | Upgrade
|
| Currency Exchange Gain (Loss) | - | -0.55 | 0.05 | -0.94 | -0.95 | Upgrade
|
| EBT Excluding Unusual Items | -35.96 | -36.49 | -49.59 | -46.03 | -43.72 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | 0.54 | 0.26 | -3.29 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | -0.06 | 6.12 | -0.01 | Upgrade
|
| Pretax Income | -35.96 | -35.96 | -49.28 | -43.21 | -43.72 | Upgrade
|
| Income Tax Expense | 0.05 | 0.05 | 0.04 | 0.34 | 0.17 | Upgrade
|
| Earnings From Continuing Operations | -36.02 | -36.01 | -49.32 | -43.55 | -43.89 | Upgrade
|
| Minority Interest in Earnings | 0.46 | 0.16 | - | 0.34 | -0.46 | Upgrade
|
| Net Income | -35.56 | -35.85 | -49.32 | -43.21 | -44.35 | Upgrade
|
| Net Income to Common | -35.56 | -35.85 | -49.32 | -43.21 | -44.35 | Upgrade
|
| Shares Outstanding (Basic) | 268 | 97 | 68 | 60 | 60 | Upgrade
|
| Shares Outstanding (Diluted) | 268 | 97 | 68 | 60 | 60 | Upgrade
|
| Shares Change (YoY) | 177.41% | 42.94% | 12.70% | - | - | Upgrade
|
| EPS (Basic) | -0.13 | -0.37 | -0.73 | -0.72 | -0.74 | Upgrade
|
| EPS (Diluted) | -0.13 | -0.37 | -0.73 | -0.72 | -0.74 | Upgrade
|
| Free Cash Flow | - | -35.37 | 14 | -76.7 | -13.24 | Upgrade
|
| Free Cash Flow Per Share | - | -0.37 | 0.21 | -1.28 | -0.22 | Upgrade
|
| Gross Margin | 9.00% | 7.06% | 25.15% | 43.64% | 45.37% | Upgrade
|
| Operating Margin | -67.98% | -34.23% | -49.03% | -45.02% | -28.23% | Upgrade
|
| Profit Margin | -75.02% | -39.02% | -58.45% | -49.00% | -30.83% | Upgrade
|
| Free Cash Flow Margin | - | -38.50% | 16.59% | -86.97% | -9.20% | Upgrade
|
| EBITDA | -29.35 | -28.58 | -38.16 | -35.22 | -36.22 | Upgrade
|
| EBITDA Margin | -61.92% | -31.10% | -45.23% | -39.94% | -25.18% | Upgrade
|
| D&A For EBITDA | 2.87 | 2.87 | 3.21 | 4.48 | 4.39 | Upgrade
|
| EBIT | -32.22 | -31.45 | -41.37 | -39.7 | -40.61 | Upgrade
|
| EBIT Margin | -67.98% | -34.23% | -49.03% | -45.02% | -28.23% | Upgrade
|
| Advertising Expenses | - | - | - | 3.57 | 8.69 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.